Agonist-induced signaling and trafficking of the μ-opioid receptor: Role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain

FEBS Letters

Volumn 415, Issue 2, 1997, Pages 200-205

  Capeyrou, Régine ^a   Riond, Joëlle ^a   Corbani, Maité ^a   Lepage, Jean François ^a   Bertin, Brigitte ^a   Emorine, Laurent J ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Desensitization; G protein; Mu opioid receptor; Phosphorylation; Receptor trafficking

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETORPHINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; OPIATE AGONIST; SERINE; THREONINE;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; FEMALE; MUTANT; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CYCLIC AMP; DIPRENORPHINE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; ENZYME ACTIVATION; ETORPHINE; FORSKOLIN; GTP-BINDING PROTEINS; GUANYLYL IMIDODIPHOSPHATE; HUMANS; MORPHINE; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, OPIOID, MU; SERINE; SIGNAL TRANSDUCTION; THREONINE;

ANIMALIA; MUS;

EID: 0031590309     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)01124-1     Document Type: Article

References (25)

1. Watson N., Linder M.E., Druey K.M., Kehrl J.H., Blumer K.J. Nature. 383:1996;172-175.
2. Wang Z., Bilsky E.J., Porreca F., Sadee W. Life Sci. 54:1994;PL339-PL350.
3. Arden J.R., Segredo V., Wang Z., Lameh J., Sadée W. J. Neurochem. 65:1995;1636-1645.
4. Raynor K., Kong H.Y., Hines J., Kong G.H., Benovic J., Yasuda K., Bell G.I., Reisine T. J. Pharmacol. Exp. Ther. 270:1994;1381-1386.
5. Pei G., Kieffer B.L., Lefkowitz R.J., Freedman N.J. Mol. Pharmacol. 48:1995;173-177.
6. Gaibelet G., Capeyrou R., Dietrich G., Emorine L.J. FEBS Lett. 408:1997;135-140.
7. Alvarez R., Daniel D.V. Anal. Biochem. 203:1992;76-80.
8. Chakrabarti S., Law P.Y., Loh H.H. Mol. Brain Res. 30:1995;269-278.
9. Avidor-Reiss T., Bayewitch M., Levy R., Matus-Leibovitch N., Nevo I., Vogel Z. J. Biol. Chem. 270:1995;29732-29738.
10. Blake A.D., Bot G., Freeman J.C., Reisine T. J. Biol. Chem. 272:1997;782-790.
11. Tolkovsky A.M. Mol. Pharmacol. 22:1982;648-656.
12. Puttfarcken P.S., Werling L.L., Cox B.M. Mol. Pharmacol. 33:1988;520-527.
13. Baumhaker Y., Gafni M., Keren O., Sarne Y. Mol. Pharmacol. 44:1993;461-467.
14. Pak Y., Kouvelas A., Scheideler M.A., Rasmussen J., O'Dowd B.F., George S.R. Mol. Pharmacol. 50:1996;1214-1222.
15. Keith D.E., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Kang L., Evans C.J., Von Zastrow M. J. Biol. Chem. 271:1996;19021-19024.
16. Trapaidze N., Keith D.E., Cvejic S., Evans C.J., Devi L.A. J. Biol. Chem. 271:1996;29279-29285.
17. Maeda S., Lameh J., Mallet W.G., Philip M., Ramachandran J., Sadée W. FEBS Lett. 269:1990;386-388.
18. Szele F.G., Pritchett D.B. Mol. Pharmacol. 43:1993;915-920.
19. Roth B.L., Choudhary M.S., Khan N., Uluer A.Z. J. Pharmacol. Exp. Ther. 280:1997;576-583.
20. Avidor-Reiss T., Nevo I., Levy R., Pfeuffer T., Vogel Z. J. Biol. Chem. 271:1996;21309-21315.
21. Barker E.L., Sanders-Bush E. Mol. Pharmacol. 44:1993;725-730.
22. Nantel F., Marullo S., Krief S., Strosberg A.D., Bouvier M. J. Biol. Chem. 269:1994;13148-13155.
23. Faurobert E., Ching-Kang C., Hurley J.B., Teng D.H. J. Biol. Chem. 271:1996;10256-10262.
24. Von Zastrow M., Kobilka B.K. J. Biol. Chem. 267:1992;3530-3538.
25. Lohse M.J. Biochim. Biophys. Acta. 1179:1993;171-188.